Recent Articles
Can VEGFR Antibodies Become a Ne...
Th1/Th2 Subset Differentiation: ...
Paired Antibodies for Progestero...
B7‑H3‑Targeted Antibody Tools: Investigating a Dual‑Function B7‑Family Immune...
Explore basic‑immunology research of B7‑H3 (CD276), a B7‑family type‑I transmembrane glycoprotein with dual co‑stimulatory‑co‑inhibitory properties. This article covers its unique extracellular domain architecture, post‑translational protein regulation, conflicting immune‑cell functional readouts,...
B7‑H3‑Targeted Antibody Tools: Investigating a Dual‑Function B7‑Family Immune...
Explore basic‑immunology research of B7‑H3 (CD276), a B7‑family type‑I transmembrane glycoprotein with dual co‑stimulatory‑co‑inhibitory properties. This article covers its unique extracellular domain architecture, post‑translational protein regulation, conflicting immune‑cell functional readouts,...
Read More
HER3‑DXd (U3‑1402): Basic‑Research Perspectives on an HER3‑Targeted Antibody‑...
Delve into basic‑science research for HER3‑DXd (patritumab deruxtecan, U3‑1402), an HER3‑targeted DXd‑based antibody‑drug conjugate. Explore HER3 EGFR‑family signalling, PI3K‑AKT oncogenic cascades, bystander cytotoxicity, drug‑resistance bypass pathways, CelTIL‑score biomarker research, and...
HER3‑DXd (U3‑1402): Basic‑Research Perspectives on an HER3‑Targeted Antibody‑...
Delve into basic‑science research for HER3‑DXd (patritumab deruxtecan, U3‑1402), an HER3‑targeted DXd‑based antibody‑drug conjugate. Explore HER3 EGFR‑family signalling, PI3K‑AKT oncogenic cascades, bystander cytotoxicity, drug‑resistance bypass pathways, CelTIL‑score biomarker research, and...
Read More
T‑DXd (DS‑8201): Pre‑Clinical Mechanism Insights for Next‑Generation Antibody...
Design Challenges and Optimized Linker‑Payload Engineering for Modern ADC Platforms Balancing cytotoxic potency, circulating stability and favourable pharmacokinetic profiles represents a persistent core challenge within antibody‑drug‑conjugate basic research. Research groups...
T‑DXd (DS‑8201): Pre‑Clinical Mechanism Insights for Next‑Generation Antibody...
Design Challenges and Optimized Linker‑Payload Engineering for Modern ADC Platforms Balancing cytotoxic potency, circulating stability and favourable pharmacokinetic profiles represents a persistent core challenge within antibody‑drug‑conjugate basic research. Research groups...
Read More
Mouse CD185 (CXCR5) Antibody Tools: Supporting Mechanistic Studies and Pre‑Cl...
Delve into basic‑science research on CXCL13‑CXCR5 (CD185) chemokine signalling axis, dual pro‑tumor and anti‑tumor functions within tumour microenvironment, pre‑clinical CXCR5‑targeted ADC prototype evaluation, and rat anti‑mouse CD185 antibody tools from...
Mouse CD185 (CXCR5) Antibody Tools: Supporting Mechanistic Studies and Pre‑Cl...
Delve into basic‑science research on CXCL13‑CXCR5 (CD185) chemokine signalling axis, dual pro‑tumor and anti‑tumor functions within tumour microenvironment, pre‑clinical CXCR5‑targeted ADC prototype evaluation, and rat anti‑mouse CD185 antibody tools from...
Read More
Anti‑CD3 Antibody Reagents: Core Laboratory Tools for T‑Cell‑Signalling and I...
Discover basic‑immunology research on CD3 complex (TCR‑CD3), ITAM‑driven T‑cell‑activation signalling including LCK‑ZAP70‑LAT‑NF‑κB‑NFAT cascades, anti‑CD3 monoclonal and bispecific antibody design considerations, and in‑vivo‑grade anti‑CD3 antibody reagents from ANT BIO PTE. LTD....
Anti‑CD3 Antibody Reagents: Core Laboratory Tools for T‑Cell‑Signalling and I...
Discover basic‑immunology research on CD3 complex (TCR‑CD3), ITAM‑driven T‑cell‑activation signalling including LCK‑ZAP70‑LAT‑NF‑κB‑NFAT cascades, anti‑CD3 monoclonal and bispecific antibody design considerations, and in‑vivo‑grade anti‑CD3 antibody reagents from ANT BIO PTE. LTD....
Read More
CD19‑Targeted Antibody‑Drug Conjugates: Pre‑Clinical Insights for Diffuse Lar...
Explore pre‑clinical basic research for CD19‑targeted antibody‑drug conjugates, including loncastuximab tesirine (Lonca), pyrrolobenzodiazepine (PBD) dimer payload mechanism, bystander cytotoxic effects, DLBCL experimental model readouts, and validated anti‑CD19 antibody reagents from...
CD19‑Targeted Antibody‑Drug Conjugates: Pre‑Clinical Insights for Diffuse Lar...
Explore pre‑clinical basic research for CD19‑targeted antibody‑drug conjugates, including loncastuximab tesirine (Lonca), pyrrolobenzodiazepine (PBD) dimer payload mechanism, bystander cytotoxic effects, DLBCL experimental model readouts, and validated anti‑CD19 antibody reagents from...
Read More